Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 41 - 50 of 56 reports

France Life Science Analytics Market Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034

Report Highlights France Life Science Analytics Market Size 2024: $1.8 billion France Life Science Analytics Market Size 2032: $4.2 billion CAGR: 11.2% Base Year: 2025 Forecast Period: 2026-2032 Market Definition: Advanced data analytics solutions for pharmaceutical research, clinical trials, regulatory compliance, and healthcare optimization in … Read More
Published May 2026

France Softgel Capsule Market Size, Share & Forecast 2026–2034

Report Highlights France: Advanced pharmaceutical manufacturing hub with strong regulatory framework Softgel Capsule Market: Gelatin and plant-based encapsulation solutions for pharmaceuticals, nutraceuticals, and cosmetics Market Size 2024: €287.4 million Market Size 2032: €421.8 million CAGR: 4.9% Base Year: 2025 Forecast Period: 2026-2032 France Softgel Capsules: … Read More
Published May 2026

France Life Sciences BPO Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 2.8 billion Market Size 2032: USD 4.6 billion CAGR: 6.4% Market Definition: Outsourced services encompassing clinical research, regulatory affairs, pharmacovigilance, data management, and manufacturing support for pharmaceutical and biotechnology companies operating in France Leading Companies: IQVIA, Syneos Health, PAREXEL, … Read More
Published May 2026

France Pegylated Drugs Market Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $2.8 billion Market Size 2032: $4.6 billion CAGR: 6.4% Base Year: 2025 Forecast Period: 2026-2032 Market Definition: Therapeutic drugs chemically modified with polyethylene glycol to improve pharmacokinetic properties and reduce immunogenicity Leading Companies: Roche, Amgen, Takeda, Merck KGaA, Pfizer France … Read More
Published May 2026

France Cardiopulmonary Disease Diagnostics Treatment Market Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: €2.8 billion Market Size 2032: €4.2 billion CAGR: 5.2% Market Definition: Medical devices, pharmaceuticals, and diagnostic technologies for cardiovascular and pulmonary disease management in France. Includes imaging systems, monitoring equipment, therapeutic devices, and prescription medications. Leading Companies: Philips Healthcare, GE … Read More
Published May 2026

France Electronic Pill Market Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034 Size, Share & Forecast 2026–2034

Report Highlights France Electronic Pill Market Size 2024: USD 28.3 million France Electronic Pill Market Size 2032: USD 89.7 million CAGR: 15.5% Electronic pills are ingestible sensors that monitor medication adherence and physiological parameters. They combine pharmaceutical compounds with wireless communication technology. Leading Companies: CapsoVision, … Read More
Published May 2026

France Tracheostomy Products Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $0.42 Billion Market Size 2034: $0.82 Billion CAGR: 7.1% CAGR (2026–2034) Market Definition: The France tracheostomy products encompasses commercially deployed products, technologies, and services within the tracheostomy products value chain across industrial, commercial, and consumer end-use segments in France. Leading … Read More
Published May 2026

France Nano Biotechnology Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $2.6 Billion Market Size 2034: $8.8 Billion CAGR: 13.0% CAGR (2026–2034) Market Definition: The France france nano biotechnology encompasses commercially deployed products, technologies, and services within the france nano biotechnology value chain across industrial, commercial, and consumer end-use segments in … Read More
Published May 2026

France Predictive Genetic Testing and Consumer Wellness Genomics Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $1.1 Billion Market Size 2034: $3.8 Billion CAGR: 13.3% CAGR (2026–2034) Market Definition: The France france predictive genetic testing and consumer wellness genomics encompasses commercially deployed products, technologies, and services within the france predictive genetic testing and consumer wellness genomics … Read More
Published May 2026

France Avian Influenza Vaccine Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $0.28 Billion Market Size 2034: $0.63 Billion CAGR: 8.5% CAGR (2026–2034) Market Definition: The France france avian influenza vaccine encompasses commercially deployed products, technologies, and services within the france avian influenza vaccine value chain across industrial, commercial, and consumer end-use … Read More
Published May 2026